PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 29735887-0 2018 Ursolic Acid Attenuates Atherosclerosis in ApoE-/- Mice: Role of LOX-1 Mediated by ROS/NF-kappaB Pathway. ursolic acid 0-12 oxidized low density lipoprotein (lectin-like) receptor 1 Mus musculus 65-70 29735887-6 2018 The evaluation in vitro suggested that UA significantly decreased endothelial LOX-1 expression induced by LPS both in mRNA and protein levels. ursolic acid 39-41 oxidized low density lipoprotein (lectin-like) receptor 1 Mus musculus 78-83 29735887-11 2018 The enhanced expression of LOX-1 in atherosclerotic aorta was also dramatically decreased by administration of UA. ursolic acid 111-113 oxidized low density lipoprotein (lectin-like) receptor 1 Mus musculus 27-32 29735887-12 2018 Taken together, these results suggested that UA, with anti-atherosclerotic activity through inhibition of LOX-1 mediated by ROS/NF-kappaB signaling pathways, may become a valuable vascular protective candidate for the treatment of atherosclerosis. ursolic acid 45-47 oxidized low density lipoprotein (lectin-like) receptor 1 Mus musculus 106-111